Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tildacerfont placebo-controlled trial in adults with classic congenital adrenal hyperplasia
NL-OMON52645Phase 2Not yet recruiting
- Sponsor
- Spruce Biosciences, Inc.
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of tildacerfont, sponsored by Spruce Biosciences, Inc. Planned start Feb 2021; status: not yet recruiting.
02
Drugs
tildacerfont
Beyond the preview
Go deeper on NL-OMON52645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52645.